Brian Park, PharmD, Author at The Cardiology Advisor
Brian Park, PharmD

Brian Park, PharmD

Drug Information Specialist https://www.thecardiologyadvisor.com
Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Vascepa Approved to Cut Risk for CV Events in High-Risk Patients With Elevated Triglycerides

The Food and Drug Administration (FDA) has approved the use of Vascepa (icosapent ethyl; Amarin Pharma) as an adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients with elevated triglyceride (TG) levels (≥150mg/dL) and established CV disease or diabetes mellitus…

Next post in Arrhythmia